#Biotech Markets

Explore our comprehensive coverage of biotech markets, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

1Articles

1Authors

2Total Views

The Blockbuster Recast: Why the GLP-1 Alzheimer's Failure is Rewiring Biotech Capital Markets

Featured

By Katherine Anne WhitfieldAug 18, 2026

The Blockbuster Recast: Why the GLP-1 Alzheimer's Failure is Rewiring Biotech Capital Markets

Novo Nordisk's Phase 3 EVOKE trial failure for oral semaglutide in Alzheimer's disease has shattered the biotech industry's $50 billion bet on repurpo...

Read Full Story →

#Biotech Markets

The Blockbuster Recast: Why the GLP-1 Alzheimer's Failure is Rewiring Biotech Capital Markets

Recent Articles